“…For example, lncRNA Cerox1 has been described as a modulator of OXPHOS, by binding miR-488-3p in the cytoplasm and preventing its inhibitory effect on the complex I transcripts [227]. However, the field of ncRNAs in mitochondria is heavily understudied, with disappointingly small study overlap and rare replications of findings, and direct association between ncRNAs and mitochondrial disease is yet to be reported [216] In the last decade, the ribosome profiling data and proteomic analyses identified a surprisingly large number of micropeptides* derived from upstream open reading frames (uORFs*), as well as ORFs corresponding to the lncRNAs [125,[228][229][230][231], arguing for the coding potential of noncoding regions and faults in current genome annotation (Box 3). More than twenty ncRNA-encoded proteins have been characterized in depth [235], including the mtDNA-encoded humanin, MOTS-c, and SHLPs [236][237][238], with roles in mitochondrial bioenergetics and metabolism, and mitoregulin, involved in the formation of OXPHOS supercomplexes, fatty acid oxidation, and Ca 2+ dynamics [239].…”